Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Malignant pleural mesothelioma: Pemetrexed in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.
Non-small cell lung cancer: Pemetrexed in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (see Pharmacology: Pharmacodynamics under Actions).
Pemetrexed is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-squamous non-small cell lung cancer patients whose disease has not progressed immediately following platinum-based chemotherapy (see Pharmacology: Pharmacodynamics under Actions).
Pemetrexed is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (see Pharmacology: Pharmacodynamics under Actions).

Pemetrexed Advagen Indications/Uses

pemetrexed

Manufacturer:

Advagen